Isn't Creasy known for investing in a large number of specs. For every 10, 9 fail. Who's to say whether MYL is the 1.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025